Intuitive Surgical stock jumped late Thursday on better-than-expected fourth-quarter profit following a disappointing ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

The bullish case for the stock remains strong.

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of ...

The robotic surgery pioneer posted adjusted earnings per share of $2.53, significantly above the analyst consensus of $2.26. Revenue climbed to $2.87 billion, exceeding the $2.75 billion estimate and ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Demand for robotic surgery is growing faster than the number of surgical robots being sold.

Intuitive Surgical’s ISRG third-quarter 2025 commentary underscored that da Vinci 5 is not merely a hardware refresh, but a ...

Intuitive Surgical's stock is poised to return over 60% in 2024, driven by strong tailwinds in the MedTech industry and elevated capital investments. The da Vinci 5 system has been well received, with ...

Dan Larson, a Seattle resident diagnosed with lung cancer in 2023, benefited from robotic-assisted surgery developed by Intuitive, a leader in robotic surgical technology. After undergoing two robotic ...